Event Future event

The 8th ACCESS ASIA BD Forum @ JPM 2027 Is Coming to San Francisco

San Francisco, January 10, 2027 – As the global biopharmaceutical industry gathers in San Francisco for JPM Week, The 8th ACCESS ASIA BD Forum @ JPM 2027 will bring together Asian biotech innovators, global pharmaceutical companies, investors, and business development leaders to explore cross-border partnering opportunities.

Organized by YAFO Capital and ACCESS ASIA, the Forum connects innovative assets from China, South Korea, Japan, and across Asia with international partners, facilitating access for Asian innovation to global markets through licensing, investment, and strategic collaboration. The Forum also provides a gateway for global companies to showcase their assets and access Asian markets, creating opportunities for cross-border business development and strategic partnerships.

Building on Results. Creating New Opportunities.

At the 2026 Forum, ACCESS ASIA welcomed more than 300 attendees and featured 29 company presentations, 9 keynote speakers, and 3 panel discussions. In 2027, the Forum will build on this foundation with company showcases, the Asia Innovation 100 Roadshow, industry discussions, and 1-to-1 partnering opportunities.

For pharma BD teams and investors, the Forum offers opportunities to discover emerging Asian biotech assets and potential partners. For biotech innovators, it provides a platform to showcase their pipelines and connect with international stakeholders.

The goal: turn connections into opportunities for cross-border business development.

One Forum, Multiple Ways to Connect

From Asian biotech innovation to global pharma partnering, the Forum brings together the people, assets, and opportunities shaping cross-border collaboration.

Event Details

  • Date: January 10, 2027 (Sunday)
  • Location: InterContinental, San Francisco, USA
  • Forum: 9:00 AM–5:00 PM
  • Cocktail Reception: 5:00–7:30 PM (Invitation-only)
  • Event Format: Keynotes and panel discussions · Company presentations and roadshows · 1-to-1 meetings · Poster exhibition · Networking lunch and cocktail reception

View the latest agenda: https://biotochina.org/agenda/

(The agenda and speaker lineup are subject to change.)

Choose Your Way to Participate

Whether you want to attend the Forum, arrange business development meetings, or showcase your company’s assets, there are three ways to participate.

For full ticket details and pricing, please refer to The 8th ACCESS ASIA @ JPM 2027 Ticket Information Page

Early Bird Deadline: November 10, 2026

Asia Innovation 100 Roadshow

Showcase your biotech assets to global pharma, investors, and potential licensing partners at the Asia Innovation 100 Roadshow.

Building on a program track record spanning 30+ companies, 60+ unique assets, and 4 industry events, the Roadshow aims to bring promising Asian biotech innovation to a global audience.

  • YAFO clients and partners: Eligibility under designated arrangements.
  • Roadshow Pass: Includes a 5-minute company presentation, subject to committee approval.

Join Us in San Francisco

Whether you are seeking innovative assets, evaluating investment opportunities, showcasing a biotech pipeline, or expanding your international BD network, The 8th ACCESS ASIA BD Forum @ JPM 2027 offers a platform to discover opportunities and connect with potential partners.

Join us on January 10, 2027, and connect Asian innovation with global opportunities.

Event, Partnering and Roadshow Inquiries

Wendi Xiang | YAFO Capital

wxiang@yafocapital.com

YAFO Capital | ACCESS ASIA

From Asian Innovation to Global Impact


A Proven Platform for Cross-Border Collaboration

Previous ACCESS ASIA events have brought together biotech innovators, pharmaceutical executives, investors, and business development professionals to explore cross-border opportunities.

PHOTOS FROM PREVIOUS YAFO ACCESS ASIA JPM EVENTS

Through its events and partnering network, YAFO Capital and ACCESS ASIA continue to connect Asian biotech innovation with international stakeholders, including bringing global innovation to Asian markets and support opportunities for licensing, investment, and strategic collaboration.